(Q70451192)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6414700%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

title

Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6414700%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

1 reference

1 reference

M E Scheulen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6414700%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

N Niederle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6414700%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

K Bremer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6414700%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

J Schütte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6414700%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

S Seeber

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6414700%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

publication date

1 September 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6414700%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

published in

Cancer Treatment Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6414700%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

volume

10 Suppl A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6414700%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

page(s)

93-101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6414700%20AND%20SRC:MED&resulttype=core&format=json

[Chemotherapy in advanced sarcomas (author's transl)]

11 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980013-9

7 January 2021

Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980013-9

7 January 2021

Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980013-9

7 January 2021

Prophylactic alkalization of the urine during cytostatic tumor treatment with the oxazaphosphorine derivatives, cyclophosphamide and ifosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980013-9

7 January 2021

Ifosfamide in the treatment of recurrent or disseminated lung cancerA phase II study of two dose schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980013-9

7 January 2021

Pronounced antiemetic activity of the antipsychotic drug levomepromacine (L) in patients receiving cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980013-9

7 January 2021

Treatment of refractory malignant lymphomas with ifosfamide/etoposide combination chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980013-9

7 January 2021

Etoposide and ifosfamide in combination for inoperable carcinoma of the bronchus

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980013-9

7 January 2021

Combined chemotherapy of metastasing melanoblastoma using ifosfamide and cis-platinum (II)-diamminodichloride (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980013-9

7 January 2021

10.1016/S0305-7372(83)80013-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6414700%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6414700%20AND%20SRC:MED&resulttype=core&format=json